Elevance Health, Inc. (ELV)
NYSE: ELV · Real-Time Price · USD
346.28
+1.07 (0.31%)
Oct 23, 2025, 4:00 PM EDT - Market closed
Elevance Health Employees
Elevance Health had 104,200 employees as of December 31, 2024. The number of employees decreased by 700 or -0.67% compared to the previous year.
Employees
104,200
Change (1Y)
-700
Growth (1Y)
-0.67%
Revenue / Employee
$1,869,674
Profits / Employee
$53,100
Market Cap
76.96B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 104,200 | -700 | -0.67% |
| Dec 31, 2023 | 104,900 | 2,600 | 2.54% |
| Dec 31, 2022 | 102,300 | 4,100 | 4.18% |
| Dec 31, 2021 | 98,200 | 14,800 | 17.75% |
| Dec 31, 2020 | 83,400 | 12,800 | 18.13% |
| Dec 31, 2019 | 70,600 | 6,700 | 10.49% |
| Dec 31, 2018 | 63,900 | 7,900 | 14.11% |
| Dec 31, 2017 | 56,000 | 3,000 | 5.66% |
| Dec 31, 2016 | 53,000 | 0 | - |
| Dec 31, 2015 | 53,000 | 1,500 | 2.91% |
| Dec 31, 2014 | 51,500 | 3,300 | 6.85% |
| Dec 31, 2013 | 48,200 | 4,700 | 10.80% |
| Dec 31, 2012 | 43,500 | 5,800 | 15.38% |
| Dec 31, 2011 | 37,700 | 200 | 0.53% |
| Dec 31, 2010 | 37,500 | -3,000 | -7.41% |
| Dec 31, 2009 | 40,500 | -2,400 | -5.59% |
| Dec 31, 2008 | 42,900 | 1,200 | 2.88% |
| Dec 31, 2007 | 41,700 | -300 | -0.71% |
| Dec 31, 2006 | 42,000 | 0 | - |
| Dec 31, 2005 | 42,000 | 4,000 | 10.53% |
| Dec 31, 2004 | 38,000 | 17,870 | 88.77% |
| Dec 31, 2003 | 20,130 | 630 | 3.23% |
| Dec 31, 2002 | 19,500 | 4,700 | 31.76% |
| Dec 31, 2001 | 14,800 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ELV News
- 2 hours ago - Elevance Health: Q3 Figures Underscore Slow But Steady Recovery - Seeking Alpha
- 1 day ago - US health insurance premiums rose to $27,000 for families in 2025 - Reuters
- 1 day ago - HistoSonics Expands Insurance Coverage for Non-Invasive Liver Tumor Treatment to 45.4 Million Elevance Health Members - Business Wire
- 1 day ago - Elevance: Checking Out The Q3 Report - Seeking Alpha
- 2 days ago - Elevance Health, Inc. (ELV) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 2 days ago - Elevance Health's Profits Eclipse $1.1 Billion Despite Rising Costs - Forbes
- 2 days ago - Elevance Health Quarterly Profit Climbs as Memberships Slip - WSJ
- 2 days ago - Elevance beats quarterly profit estimates as medical costs remained in check - Reuters